NewsBenzingaMiniMed recibe la autorización de la FDA para su primera bomba de insulina sin tubo, la MiniMed Fit; el despliegue por fases comenzará en la primavera de 2027 MiniMed recibe la autorización de la FDA para su primera bomba de insulina sin tubo, la MiniMed Fit; el despliegue por fases comenzará en la primavera de 2027 Benzinga 2026.11.16 14:09 (GMT+0) Open on Benzinga Other news Citigroup Maintains Buy on Kodiak AI, Lowers Price Target to $7 Swoosh and a Miss: Nike Investor Day Leaves Wall Street Cold-Footed Wall Street Says the AI Trade Is Over — ETF Investors Aren’t Acting Like It Citigroup Maintains Neutral on Westlake, Lowers Price Target to $65 Citigroup Maintains Neutral on LyondellBasell Industries, Lowers Price Target to $66 Caterpillar's 'Best-In-Class' Construction Business Is Getting Overlooked, Analyst Says